KRISTYN ELISH: Open Payments
NPI 1578725768 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$368 in 18 payments from 11 companies in 2025. Trend: 2023 $435 · 2024 $273 · 2025 $368
Food & beverage: $348Speaker / faculty: $20
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $73 |
| Novartis Pharmaceuticals Corporation | 3 | $52 |
| Amgen Inc. | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Esperion Therapeutics, Inc. | 2 | $33 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $30 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $27 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| Becton, Dickinson and Company | 1 | $20 |
| SCPHARMACEUTICALS INC. | 1 | $20 |
Products named: LEQVIO, FARXIGA, NEXLETOL, JOURNAVX, Wegovy, JARDIANCE, Kerendia, Ozempic.
Industry payments across NY — which companies pay providers there.
